AU3776395A - Inhibition of herpesviridae infection by antisense oligonucleotides - Google Patents

Inhibition of herpesviridae infection by antisense oligonucleotides

Info

Publication number
AU3776395A
AU3776395A AU37763/95A AU3776395A AU3776395A AU 3776395 A AU3776395 A AU 3776395A AU 37763/95 A AU37763/95 A AU 37763/95A AU 3776395 A AU3776395 A AU 3776395A AU 3776395 A AU3776395 A AU 3776395A
Authority
AU
Australia
Prior art keywords
inhibition
antisense oligonucleotides
herpesviridae infection
herpesviridae
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37763/95A
Inventor
Kameron W. Maxwell
Bernard Roizman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genta Inc
Original Assignee
Genta Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genta Inc filed Critical Genta Inc
Publication of AU3776395A publication Critical patent/AU3776395A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C12N15/1133—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against herpetoviridae, e.g. HSV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/321—2'-O-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/352—Nature of the modification linked to the nucleic acid via a carbon atom
    • C12N2310/3521—Methyl

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AU37763/95A 1990-08-15 1995-11-09 Inhibition of herpesviridae infection by antisense oligonucleotides Abandoned AU3776395A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56850190A 1990-08-15 1990-08-15
US568501 1990-08-15

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU86176/91A Division AU8617691A (en) 1990-08-15 1991-08-13 Inhibition of herpesviridae infection by antisense oligonucleotides

Publications (1)

Publication Number Publication Date
AU3776395A true AU3776395A (en) 1996-02-29

Family

ID=24271562

Family Applications (2)

Application Number Title Priority Date Filing Date
AU86176/91A Abandoned AU8617691A (en) 1990-08-15 1991-08-13 Inhibition of herpesviridae infection by antisense oligonucleotides
AU37763/95A Abandoned AU3776395A (en) 1990-08-15 1995-11-09 Inhibition of herpesviridae infection by antisense oligonucleotides

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU86176/91A Abandoned AU8617691A (en) 1990-08-15 1991-08-13 Inhibition of herpesviridae infection by antisense oligonucleotides

Country Status (10)

Country Link
EP (1) EP0547149A4 (en)
JP (1) JPH06500469A (en)
KR (1) KR930701105A (en)
AU (2) AU8617691A (en)
CA (1) CA2089476A1 (en)
IE (1) IE912883A1 (en)
IL (1) IL99172A (en)
NZ (1) NZ239372A (en)
TW (1) TW226408B (en)
WO (1) WO1992003051A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2105595A1 (en) * 1992-09-23 1994-03-24 Ramaswamy Narayanan Antisense polynucleotides
DE69514351T2 (en) * 1994-06-01 2000-08-10 Hybridon Inc Branched oligonucleotides as pathogen-inhibiting agents
AU713611B2 (en) * 1994-10-28 1999-12-09 Delft Diagnostic Laboratory B.V. New polynucleic acid sequences for use in the detection and differentiation of prokaryotic organisms
CA2223032A1 (en) * 1997-02-21 1998-08-21 Smithkline Beecham Corporation Use of hsv-1 ul-15 and vp5 in identifying anti-viral agents
MXPA05002791A (en) 2002-09-13 2005-12-05 Replicor Inc Non-sequence complementary antiviral oligonucleotides.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ209840A (en) * 1983-10-17 1988-11-29 Kaji Akira A method of inhibiting viral propagation by hybridising dna with the viral rna thus blocking its action
US5248670A (en) * 1990-02-26 1993-09-28 Isis Pharmaceuticals, Inc. Antisense oligonucleotides for inhibiting herpesviruses
EP0656942A1 (en) * 1990-09-21 1995-06-14 University Of Maryland Compositions and methods for inhibiting growth or replication of viruses

Also Published As

Publication number Publication date
EP0547149A1 (en) 1993-06-23
NZ239372A (en) 1997-06-24
AU8617691A (en) 1992-03-17
TW226408B (en) 1994-07-11
CA2089476A1 (en) 1992-02-16
IL99172A0 (en) 1992-07-15
IL99172A (en) 1999-03-12
KR930701105A (en) 1993-06-11
IE912883A1 (en) 1992-02-26
WO1992003051A1 (en) 1992-03-05
EP0547149A4 (en) 1993-09-01
JPH06500469A (en) 1994-01-20

Similar Documents

Publication Publication Date Title
HU9402822D0 (en) Antisense oligonucleotide inhibition of papillomavirus
AU6110990A (en) Use of viruses against undesirable micro-organisms
AU1163192A (en) Sanitary napkin
AU6479696A (en) Antisense inhibition of hepatitis b virus replication
AU3292693A (en) Sanitary napkins
GB9016973D0 (en) Viral growth inhibition
AU3634095A (en) Inhibition of hemoflagellates by camptothecin compounds
AU7935091A (en) Syndiotactic crystalline copolymers of propylene
AU8551191A (en) Inhibition of scale
AU5072793A (en) Sanitary napkin
AU6601690A (en) Selective inhibition of gene expression by photoactivatable oligonucleotides
AU652775B2 (en) Scale inhibition
AU3776395A (en) Inhibition of herpesviridae infection by antisense oligonucleotides
HU9500979D0 (en) Antisense oligonucleotide inhibition of the ras gene
AU3126595A (en) Antisense oligonucleotides of pleiotrophin
GB9020541D0 (en) Viral growth inhibition
AU2584395A (en) Antisense oligomers for inhibiting human papillomaviruses
AU6215390A (en) Inhibition of deposition in aqueous systems
AU1753392A (en) Purification of mullerian inhibiting substance
AU1728995A (en) Inhibition of vacuolar h+ -atpase by phosphorothioate oligonucleotides
AU6578298A (en) Antisense inhibition of angiogenin expression
AU2387292A (en) Antisense oligonucleotides
GB9019611D0 (en) The use of macrolide compounds for cytomegalovirus infection
AU5086393A (en) Antisense oligonucleotides to cyclin d1 proto-oncogene
AU7302191A (en) Inhibition of transcription by double-stranded oligonucleotides